Dec 2023 $2 M No. 5 Under $2 million 8
Morphogenesis Inc.: Raise no. 5, Dec 2023 × Investors in this round 8 investors had bought by the notice of Dec 27, 2023: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $15 M offered; $13 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $133,200
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Dan Dearborn · Executive Officer James Bianco · Executive Officer, Director Alan List · Director George Ng · Director James Manuso · Director Kiran Patel · Director Michael Lawman · Director Patricia Lawman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Paulson Investment Company LLC (CRD 5670) · Portland, Oregon Sold in all US states Remarks in the notice On fees: “"Paulson Investment Company, LLC (""Paulson"") will be paid a cash placement fee equal to 6% of gross proceeds of Offering. Issuer will also issue to Paulson a number of shares of Common Stock equal to 2% of the gross proceeds of Offering divided by 1.5."”Signed by Dan Dearborn, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 27, 2023. Read the notice at the SEC .
debt, options SEC Jun 2022 $9 M No. 4 $2 to $10 million 2
Morphogenesis Inc.: Raise no. 4, Jun 2022 × Investors in this round 2 investors had bought by the notice of Jul 11, 2022: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $20 M offered; $11 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Florida People named in the notice Dan Dearborn · Executive Officer James Bianco · Executive Officer, Director George C. Ng · Director Kiran C. Patel · Director Michael C. Lawman · Director Patricia C. Lawman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dan Dearborn, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 11, 2022. Read the notice at the SEC .
equity SEC Oct 2021 $5 M No. 3 $2 to $10 million 4
Morphogenesis Inc.: Raise no. 3, Oct 2021 × Investors in this round 4 investors had bought by the notice of Nov 19, 2021: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Florida People named in the notice James Bianco · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dan Dearborn, Cfo. Source: SEC Form D, newest notice filed Nov 19, 2021. Read the notice at the SEC .
equity SEC Oct 2020 $4 M No. 2 $2 to $10 million 39
Morphogenesis Inc.: Raise no. 2, Oct 2020 × Investors in this round 39 investors had bought by the notice of Sep 29, 2021: 39 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $11 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $304,355
Finders' fees none
Paid to its own people $378,000 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Florida People named in the notice Daniel Dearborn · Executive Officer James Bianco · Executive Officer, Director George Ng · Director Kiran Patel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Paulson Investment Company, LLC (CRD 5670) · Lake Oswego, Oregon Sold in CA, CT, FL, HI, IL, IN, MI, NC, NJ, NY, OH, PR, TN, TX, VA Remarks in the notice On the use of proceeds: “Salaries for 3 executive officers assuming the entire $10,000,000 is raised.”Signed by Dan Dearborn, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Sep 29, 2021. Read the notice at the SEC .
equity SEC Aug 2017 $3 M No. 1 $2 to $10 million 40
Morphogenesis Inc.: Raise no. 1, Aug 2017 × Investors in this round 40 investors had bought by the notice of Jan 12, 2018: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $15 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $1,200,000
Finders' fees none
Paid to its own people $376,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Florida People named in the notice Michael John Lawman · Executive Officer, Director Patricia Dianne Lawman · Executive Officer, Director Scott Dianne Slayton · Executive Officer David John Bergmann · Director David John Lawman · Director Grahame John Cook · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Paulson Investment Company, LLC (CRD 5670) · broker-dealer Skyway Capital Markets, LLC (CRD 124630) · Chicago, Illinois Sold in FL, GA, MD, NY, VA Skyway Capital Markets, LLC (CRD 124630) · broker-dealer Paulson Investment Company, LLC (CRD 5670) · Tampa, Florida Sold in FL, GA, MD, NY, VA Remarks in the notice On fees: “Assuming sale of entire offering. Plus warrants to purchase 3,750,000 shares at a purchase price of $0.52/share.”On the use of proceeds: “Figure includes 2018 salaries for Patricia Lawman and Michael Lawman and consulting fees for Scott Slayton.”Signed by Patricia D Lawman, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 12, 2018. Read the notice at the SEC .
equity SEC